Researchers will use biomedical chips as part of a shift toward more accurate, non-animal models of eye disease to accelerate discoveries and the development of new treatments.

A digital rendering of the cornea-on-a-chip, with colored lines feeding a dome in the center
Conceptual rendering of the cornea-on-a-chip device. Human corneal cells grow on a flexible dome that mimics the eye’s shape and stretch, helping researchers study keratoconus, a disease in which the cornea thins and bulges into a cone.

A $2.4 million National Institutes of Health (NIH) grant awarded to the University of Utah John and Marcia Price Department of Engineering’s Jungkyu “Jay” Kim, PhD, will supercharge research using biomedical chip technology to study keratoconus, a potentially blinding disease that causes the eye’s cornea to thin and bulge.

What starts as a small bulge on the cornea, the clear dome at the front of the eye, can continue to steepen until vision blurs beyond what eyeglasses and treatments aimed to slow damage can correct. Little is known about why keratoconus progresses, and up to one in five patients eventually need a cornea transplant, making the disease one of the leading reasons for cornea transplant surgery worldwide.

The four-year, R01 grant from the NIH’s National Eye Institute will allow Kim to test a hypothesis that could provide the first detailed explanation of disease progression: A feedback loop caused by the shape of the cornea itself.

“We think the new shape becomes the problem,” explained Kim, associate professor of mechanical engineering at the Price College of Engineering, with joint appointments in biomedical engineering and the John A. Moran Eye Center. “The cone shape creates stress, the stress damages cells, the damage thins the tissue, and thinner tissue bulges more. Each turn makes the next one worse. At some point the disease stops needing its original cause.”

Until now, testing that hypothesis has been nearly impossible.

“There’s no animal model that truly reproduces keratoconus,” Kim explained. “And you can’t take a donated cornea, reshape it, and see how the cells respond over time.”

With natural corneas out of the question, Kim’s lab has been building one. The cornea-on-a-chip is a small transparent device holding living human corneal cells on a thin membrane that can be curved on demand by hydraulic pressure — from the gentle dome of a healthy eye through the steep geometries of keratoconus. Curvature is now a dial the researchers can turn across all three corneal cell layers in a single chip.

In work published in Nature Communications last year Kim’s group used that dial and got a result they did not expect. Curvature alone—no chemical trigger, no injury, nothing but a change in shape—was enough to push healthy corneal cells toward a fibrotic, scar-forming state and switch on inflammatory genes.

An undulating surface
Microscope image of the corneal surface on the cornea chip. The uneven, raised features are mucus deposits on the cell surface, resembling the mucus layer of the tear film on the native ocular surface.

“That was the moment this became more than just an engineering project,” Kim said.

The grant has two interdependent questions. The first asks what is happening: the researchers need to know at what curvature ordinary mechanical stress tips into damage, how that damage spreads between the cornea’s layers, and whether there is a point before which the cycle can be disrupted.

The second asks what to do about it. Once the lab knows which molecular pathways carry the damage, it can test any drugs developed to block them—applied to the chip both before the cornea steepens and after damage is underway.

“Knowing the mechanism isn’t the finish line,” Kim said. “A drug that works before the disease takes hold and a drug that works after are different problems, and patients see ophthalmologists at every stage.”

The work spans two Price Engineering departments and the Moran Eye Center. Jiyoung Chang, associate professor in mechanical engineering, fabricates the ultrathin membranes that stand in for the cornea’s internal layers. Michael Yu, a professor in biomedical engineering, analyzes collagen damage and the proteins that shift under mechanical stress. Moran Eye Center cornea surgeon Amy Lin, MD, will provide Kim with a key resource for the research: corneal tissue from keratoconus patients undergoing corneal transplants, and data on the tissue’s curvature and thickness.

False color micrograph of criss-crossing cells
Highlighted in red and blue, the internal cornea stroma living on the chip demonstrate orthogonal cell alignment, mimicking human cornea features.

The chip belongs to a category regulators call “New Approach Methodologies”: human-based laboratory models meant to answer questions that currently require animal studies. Federal interest in them has grown under the FDA Modernization Act, and eye research is a prime candidate since animal eyes differ significantly from human eyes in many ways.

“Every one of these chips is a question we can answer without an animal,” Kim said. “In eye research that matters more than most, because for a lot of what we need to know, there isn’t a good animal model to begin with.”

The lab is pursuing a related line abroad. A separate award from the Korea Health Industry Development Institute supports a collaboration with Asan Medical Center in Seoul studying how corneal nerves regrow after transplant surgery — a process that leaves many patients with reduced sensation in the eye, for reasons that remain poorly understood.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.